Endogenous nitric oxide counteracts antigen-induced bronchoconstriction

Eur J Pharmacol. 1993 Nov 16;249(3):R7-8. doi: 10.1016/0014-2999(93)90532-m.

Abstract

In anesthetized, artificially ventilated guinea pigs immunized against ovalbumin, challenge with aerosolized ovalbumin (0.1 mg) elicited a substantial and sustained increase of insufflation pressure. The inhibitor of endogenous nitric oxide (NO) synthesis, L-NAME (N omega-nitro-L-arginine methylester, 30 mg kg-1 i.v.), markedly augmented the response, the potentiation of which could be prevented by NO (20 p.p.m.) in the inhaled air. The results indicate an inhibitory effect of endogenous NO on antigen-induced bronchoconstriction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerosols
  • Animals
  • Arginine / administration & dosage
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Blood Pressure / drug effects
  • Bronchoconstriction* / drug effects
  • Guinea Pigs
  • Heart Rate / drug effects
  • Immunization
  • Injections, Intravenous
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / physiology*
  • Ovalbumin / immunology

Substances

  • Aerosols
  • Nitric Oxide
  • Ovalbumin
  • Arginine
  • NG-Nitroarginine Methyl Ester